Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Bone Marrow Mononuclear Cells for Cerebral Palsy
NCT02569775Phase 2Completed
- Sponsor
- Vinmec Healthcare System
- Start
- Apr 2014
- Primary completion
- Aug 2015
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous bone marrow-derived mononuclear cell in cerebral palsy (CP), sponsored by Vinmec Healthcare System. Started Apr 2014; status: completed.
02
Drugs
autologous bone marrow-derived mononuclear cell
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on NCT02569775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02569775.